We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
-12.99%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$59.5M
AUM Growth
+$25.5M
Cap. Flow
+$23.8M
Cap. Flow %
39.98%
Top 10 Hldgs %
59.39%
Holding
29
New
13
Increased
5
Reduced
2
Closed
3

Top Buys

Rank Stock Value
1
LH icon
Labcorp
LH
+$4.19M
2
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$3.88M
3
YARW
Yarrow Bioscience
YARW
+$3.7M
4
AZN icon
AstraZeneca
AZN
+$3.53M
5
SPXU icon
ProShares UltraPro Short S&P 500
SPXU
+$3.37M

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$1.67M
2
VKTX icon
Viking Therapeutics
VKTX
+$1.54M
3
GILD icon
Gilead Sciences
GILD
+$1.38M
4
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
+$1.17M

Sector Composition

Rank Sector Weight
1 Healthcare 72.72%
2 Miscellaneous 26.63%
3 Consumer Staples 0.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
1
AbbVie
ABBV
$456B
$3.81M 6.41%
50,000
– –
GSK icon
2
GSK
GSK
$101B
$3.79M 6.37%
80,000
– –
GILD icon
3
CALL
Gilead Sciences
GILD
$185B
$3.74M 6.29%
+50,000
New +$3.45M
GILD icon
4
Gilead Sciences
GILD
$185B
$3.74M 6.29%
50,000
-20,000
-29% -$1.38M
SPXU icon
5
ProShares UltraPro Short S&P 500
SPXU
$384M
$3.62M 6.09%
+1,500
New +$3.37M
CAH icon
6
Cardinal Health
CAH
$54.7B
$3.6M 6.05%
75,000
+40,000
+114% +$2.08M
MCK icon
7
McKesson
MCK
$104B
$3.38M 5.69%
25,000
+15,000
+150% +$2.2M
AZN icon
8
AstraZeneca
AZN
$255B
$3.35M 5.64%
+37,500
New +$3.53M
LH icon
9
Labcorp
LH
$27.3B
$3.16M 5.32%
+29,100
New +$4.19M
SPXL icon
10
CALL
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$7.01B
$3.13M 5.26%
+120,000
New +$6.75M
JAZZ icon
11
Jazz Pharmaceuticals
JAZZ
$16.3B
$2.99M 5.03%
+30,000
New +$3.88M
ALXN
12
DELISTED
Alexion Pharmaceuticals
ALXN
$2.69M 4.53%
+30,000
New +$2.94M
COR icon
13
Cencora
COR
$61.3B
$2.65M 4.47%
30,000
+10,000
+50% +$881K
TYME
14
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$2.39M 4.03%
2,175,000
– –
YARW
15
Yarrow Bioscience
YARW
$104M
$2.28M 3.83%
+236
New +$3.7M
SPXU icon
16
CALL
ProShares UltraPro Short S&P 500
SPXU
$384M
$1.81M 3.04%
+750
New +$1.68M
CLVS
17
DELISTED
Clovis Oncology, Inc.
CLVS
$1.59M 2.67%
250,000
+100,000
+67% +$802K
CVS icon
18
CVS Health
CVS
$119B
$1.48M 2.49%
25,000
-25,000
-50% -$1.67M
ATRS
19
DELISTED
Antares Pharma, Inc.
ATRS
$1.18M 1.98%
500,000
+200,000
+67% +$680K
WBA
20
DELISTED
Walgreens Boots Alliance
WBA
$1.14M 1.92%
+25,000
New +$1.27M
BIS icon
21
CALL
ProShares UltraShort NASDAQ Biotechnology
BIS
$1.77M
$1.06M 1.78%
+9,375
New +$1.07M
AMRN
22
CALL
Amarin Corp
AMRN
$299M
$800K 1.35%
+10,000
New +$3.32M
CLVS
23
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
$636K 1.07%
100,000
– –
ADMS
24
CALL
DELISTED
Adamas Pharmaceuticals
ADMS
$578K 0.97%
200,000
– –
VKTX icon
25
CALL
Viking Therapeutics
VKTX
$3.95B
$468K 0.79%
+100,000
New +$615K
1
2

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q1 2020 Portfolio in Review

As of Q1 2020, Healthcare Value Capital held 29 positions worth $59.5M, up 75% from $34M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Healthcare Value Capital deployed $23.8M of net new capital in Q1 2020, opening 13 new positions and adding to 5 existing holdings. Its largest new stake was Labcorp: 29,100 shares worth $3.16M.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, down from 93% a quarter earlier, followed by Miscellaneous and Consumer Staples.

On the sell side, the largest reduction was CVS Health, an estimated $1.67M trimmed.

  • Healthcare Value Capital's largest Q1 2020 buy was Labcorp: 29,100 shares worth $3.16M.
  • Healthcare Value Capital added most to McKesson in Q1 2020, an estimated $2.2M increase.
  • Healthcare Value Capital's biggest Q1 2020 reduction was CVS Health, cutting an estimated $1.67M.
  • Healthcare Value Capital fully exited Viking Therapeutics in Q1 2020, selling an estimated $1.54M.
  • Healthcare Value Capital's ten largest holdings make up 59% of its $59.5M portfolio in Q1 2020.
  • Healthcare Value Capital opened 13 new positions and closed 3 in Q1 2020.
  • Healthcare Value Capital's portfolio value rose 75% quarter-over-quarter to $59.5M.

Based on Healthcare Value Capital's 13F filing for Q1 2020, filed 15 May 2020.